Bowlin SJ - Search Results

1

Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects.

Brothers CH, Hernandez JE, Cutrell AG, Curtis L, Ait-Khaled M, Bowlin SJ, Hughes SH, Yeo JM, Lapierre DH. Brothers CH, et al. Among authors: bowlin sj. J Acquir Immune Defic Syndr. 2009 May 1;51(1):20-8. doi: 10.1097/QAI.0b013e31819ff0e6. J Acquir Immune Defic Syndr. 2009. PMID: 19282778

2

Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case-control analysis in a health-insured population.

Mundy LM, Youk AO, McComsey GA, Bowlin SJ. Mundy LM, et al. Among authors: bowlin sj. AIDS. 2012 Jun 1;26(9):1073-82. doi: 10.1097/QAD.0b013e328351997f. AIDS. 2012. PMID: 22301413

3

The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.

Koro CE, Bowlin SJ, Stump TE, Sprecher DL, Tierney WM. Koro CE, et al. Among authors: bowlin sj. Am Heart J. 2006 Mar;151(3):755.e1-755.e6. doi: 10.1016/j.ahj.2005.12.007. Am Heart J. 2006. PMID: 16504648

4

Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States.

Koro CE, Lee BH, Bowlin SJ. Koro CE, et al. Among authors: bowlin sj. Clin Ther. 2009 Nov;31(11):2608-17. doi: 10.1016/j.clinthera.2009.10.020. Clin Ther. 2009. PMID: 20110005

5

The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.

Nichols GA, Koro CE, Chan W, Bowlin SJ, Sprecher DL. Nichols GA, et al. Among authors: bowlin sj. Clin Ther. 2006 Feb;28(2):243-50. doi: 10.1016/j.clinthera.2006.02.003. Clin Ther. 2006. PMID: 16678645

6

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report.

Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Koro CE, et al. Among authors: bowlin sj. Diabetes Care. 2004 Jan;27(1):17-20. doi: 10.2337/diacare.27.1.17. Diabetes Care. 2004. PMID: 14693960

7

Thiazolidinedione-associated congestive heart failure and pulmonary edema.

Bowlin SJ, Koro CE. Bowlin SJ, et al. Mayo Clin Proc. 2004 Apr;79(4):572, 575; author reply 575-7. doi: 10.4065/79.4.572-a. Mayo Clin Proc. 2004. PMID: 15065628 Review. No abstract available.

8

Ethnic disparities and trends in glycemic control among adults with type 2 diabetes in the U.S. from 1988 to 2002.

Fan T, Koro CE, Fedder DO, Bowlin SJ. Fan T, et al. Among authors: bowlin sj. Diabetes Care. 2006 Aug;29(8):1924-5. doi: 10.2337/dc05-2238. Diabetes Care. 2006. PMID: 16873805 No abstract available.

9

Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.

Koro CE, Bowlin SJ, Weiss SR. Koro CE, et al. Among authors: bowlin sj. Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):697-703. doi: 10.1002/pds.1069. Pharmacoepidemiol Drug Saf. 2005. PMID: 15654719

10

General mortality from 1944 through 1994 for a silicon-based chemical company.

Bowlin SJ, Clark BD, Prebay RK, Klein PJ, Perkins LL. Bowlin SJ, et al. J Occup Environ Med. 2007 May;49(5):526-39. doi: 10.1097/JOM.0b013e318050c93f. J Occup Environ Med. 2007. PMID: 17495695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters